Detection of Lung Cancer by Plasma Lipids
- Conditions
- Early-Stage Lung Cancer
- Registration Number
- NCT04287712
- Lead Sponsor
- Peking University People's Hospital
- Brief Summary
There are no reliable blood-based tests currently available for early-stage lung cancer diagnosis. We try to establish a highly accurate method for detecting early-stage lung cancer by combining machine learning with untargeted and targeted metabolomics .
- Detailed Description
All plasma lipids were first detected by untargeted metabolomics methods and 9 feature lipids of early-stage lung cancer were selected by support vector machine algorithm. Then, a targeted metabolomics method was developed to detect the 9 lipids quantitatively based on multiple reaction monitoring mode. Finally, a detection model was established based on the 9 lipids.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 558
- pulmonary nodules or opacity
- plan to receive surgery
- history of other malignancies
- received anti-cancer treatment (chemotherapy, radiotherapy, targeted therapy, etc.) before surgery
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma Lipids All samples were detected together after participants recruitment and sample collection. All samples were detected within 18 months from sample collection. A detection model based on 9 lipids were developed, including 3 lysophosphatidylcholines, 5 phosphatidylcholines, and a triglyceride. The 9 lipids were detected by targeted metabolomics by mass spectrometry.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Peking University People's Hospital
🇨🇳Beijing, Beijing, China
Peking University People's Hospital🇨🇳Beijing, Beijing, China